Search Results

There are 15571 results for: content related to: IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

  1. You have free access to this content
    Quantitation of pretreatment serum interferon-γ–inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 14–22, Jama M. Darling, Jeroen Aerssens, Gregory Fanning, John G. McHutchison, David B. Goldstein, Alexander J. Thompson, Kevin V. Shianna, Nezam H. Afdhal, Michael L. Hudson, Charles D. Howell, Willem Talloen, Jacques Bollekens, Mieke De Wit, Annick Scholliers and Michael W. Fried

    Article first published online : 12 JAN 2011, DOI: 10.1002/hep.24056

  2. You have free access to this content
    Clinical utility of interleukin-28B testing in patients with genotype 1

    Hepatology

    Volume 56, Issue 1, July 2012, Pages: 367–372, Michelle Lai and Nezam H. Afdhal

    Article first published online : 3 JUL 2012, DOI: 10.1002/hep.25793

  3. Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C

    Hepatology Research

    Volume 44, Issue 12, November 2014, Pages: 1208–1216, Kentaro Matsuura, Tsunamasa Watanabe, Sayuki Iijima, Shuko Murakami, Kei Fujiwara, Etsuro Orito, Etsuko Iio, Mio Endo, Atsunori Kusakabe, Noboru Shinkai, Tomokatsu Miyaki, Shunsuke Nojiri, Takashi Joh and Yasuhito Tanaka

    Article first published online : 17 FEB 2014, DOI: 10.1111/hepr.12294

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Article first published online : 15 OCT 2013, DOI: 10.1002/hep.26880

  6. You have free access to this content
    Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

    Hepatology

    Volume 51, Issue 5, May 2010, Pages: 1523–1530, Galia Askarieh, Åsa Alsiö, Paolo Pugnale, Francesco Negro, Carlo Ferrari, Avidan U. Neumann, Jean-Michel Pawlotsky, Solko W. Schalm, Stefan Zeuzem, Gunnar Norkrans, Johan Westin, Jonas Söderholm, Kristoffer Hellstrand, Martin Lagging and DITTO-HCV and NORDynamIC Study Groups

    Article first published online : 23 DEC 2009, DOI: 10.1002/hep.23509

  7. You have free access to this content
    Abstracts 1–199

    Hepatology

    Volume 52, Issue S1, October 2010, Pages: 320A–421A,

    Article first published online : 30 SEP 2010, DOI: 10.1002/hep.23974

  8. You have free access to this content
    Human Cytomegalovirus Infection in Lung Transplant Recipients Triggers a CXCL-10 Response

    American Journal of Transplantation

    Volume 11, Issue 3, March 2011, Pages: 542–552, L. Weseslindtner, R. Nachbagauer, M. Kundi, P. Jaksch, H. Kerschner, B. Simon, L. Hatos-Agyi, A. Scheed, J.H. Aberle, W. Klepetko and E. Puchhammer-Stöckl

    Article first published online : 10 JAN 2011, DOI: 10.1111/j.1600-6143.2010.03404.x

  9. Hepatic interferon-gamma-induced protein-10 expression is more strongly associated with liver fibrosis than interleukin-28B single nucleotide polymorphisms in hepatocellular carcinoma resected patients with chronic hepatitis C

    Hepatology Research

    Volume 43, Issue 11, November 2013, Pages: 1139–1147, Hideyuki Konishi, Ken Shirabe, Shohei Yoshiya, Tetsuo Ikeda, Toru Ikegami, Tomoharu Yoshizumi, Ayae Ikawa-Yoshida, Takashi Motomura, Takasuke Fukuhara and Yoshihiko Maehara

    Article first published online : 7 FEB 2013, DOI: 10.1111/hepr.12070

  10. You have free access to this content
    Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 1018–1027, Y. ROTMAN, B. B. BORG, A. SOZA, J. J. FELD, A. A. MODI, R. LOOMBA, G. LUTCHMAN, E. RIVERA, E. DOO, M. G. GHANY, T. HELLER, A. U. NEUMANN, T. J. LIANG and J. H. HOOFNAGLE

    Article first published online : 16 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04263.x

  11. You have free access to this content
    AASLD Abstracts 1143–1352

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 817A–911A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22645

  12. You have free access to this content
    Enhancement of DNA vaccine potency by antigen linkage to IFN-γ-inducible protein-10

    International Journal of Cancer

    Volume 128, Issue 3, 1 February 2011, Pages: 702–714, Tae Heung Kang, Keon Woo Kim, Hyun Cheol Bae, Seung-Yong Seong and Tae Woo Kim

    Article first published online : 14 APR 2010, DOI: 10.1002/ijc.25391

  13. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency

    Experimental Dermatology

    Volume 13, Issue 6, June 2004, Pages: 380–390, Johanna Keyser, Jan Schultz, Kristin Ladell, Lina Elzaouk, Lucie Heinzerling, Jovan Pavlovic and Karin Moelling

    Article first published online : 1 JUN 2004, DOI: 10.1111/j.0906-6705.2004.00191.x

  14. You have free access to this content
    Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2124–2134, Jason Grebely, Jordan J. Feld, Tanya Applegate, Gail V. Matthews, Margaret Hellard, Alana Sherker, Kathy Petoumenos, Geng Zang, Ineke Shaw, Barbara Yeung, Jacob George, Suzy Teutsch, John M. Kaldor, Vera Cherepanov, Julie Bruneau, Naglaa H. Shoukry, Andrew R. Lloyd and Gregory J. Dore

    Article first published online : 8 MAY 2013, DOI: 10.1002/hep.26263

  15. You have free access to this content
    Reciprocal cross-talk between RANKL and interferon-γ–inducible protein 10 is responsible for bone-erosive experimental arthritis

    Arthritis & Rheumatism

    Volume 58, Issue 5, May 2008, Pages: 1332–1342, Han Bok Kwak, Hyunil Ha, Ha-Neui Kim, Jong-Ho Lee, Hun Soo Kim, Seungbok Lee, Hyun-Man Kim, Jung Yeon Kim, Hong-Hee Kim, Yeong Wook Song and Zang Hee Lee

    Article first published online : 25 APR 2008, DOI: 10.1002/art.23372

  16. You have free access to this content
    The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: Importance of mRNA half-life regulation

    International Journal of Cancer

    Volume 114, Issue 4, 20 April 2005, Pages: 598–605, Martina Vockerodt, Diana Pinkert, Sigrun Smola-Hess, Astrid Michels, Richard M. Ransohoff, Hans Tesch and Dieter Kube

    Article first published online : 1 DEC 2004, DOI: 10.1002/ijc.20759

  17. You have free access to this content
    Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E397–E407, Hiroki Nishikawa, Hirayuki Enomoto, Akihiro Nasu, Nobuhiro Aizawa, Masaki Saito, Akihiro Tamori, Norifumi Kawada, Toru Kimura, Yukio Osaki and Shuhei Nishiguchi

    Article first published online : 6 MAY 2014, DOI: 10.1111/hepr.12326

  18. You have free access to this content
    Increase of chemokine interferon-inducible protein-10 (IP-10) in the serum of patients with autoimmune liver diseases and increase of its mRNA expression in hepatocytes

    Clinical & Experimental Immunology

    Volume 123, Issue 2, February 2001, Pages: 271–279, K. Nishioji, T. Okanoue, Y. Itoh, S. Narumi, M. Sakamoto, H. Nakamura, A. Morita and K. Kashima

    Article first published online : 20 DEC 2001, DOI: 10.1046/j.1365-2249.2001.01391.x

  19. Modification of dendritic cells with interferon-γ-inducible protein-10 gene to enhance vaccine potency

    The Journal of Gene Medicine

    Volume 11, Issue 10, October 2009, Pages: 889–898, Tae Heung Kang, Hyun Cheol Bae, Seok-Ho Kim, Su Hong Seo, Sang Wook Son, Eun Young Choi, Seung-Yong Seong and Tae Woo Kim

    Article first published online : 20 JUL 2009, DOI: 10.1002/jgm.1371

  20. You have free access to this content
    Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)—possible immunosuppressive role of IFN-α in HIV infection

    Clinical & Experimental Immunology

    Volume 119, Issue 3, March 2000, Pages: 479–485, E. Stylianou, P. Aukrust, K. Bendtzen, F. Müller and S. S. Frøland

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2249.2000.01144.x